(AP) — Abbott Laboratories said Thursday it is buying a potential chronic pain drug from PanGenetics BV for as much as $190 million. Abbott said the drug is in early-stage clinical testing as a treatment for pain cause by arthritis. If that trial is successful, Abbott may test it against ...
